MHRA23 Apr 2026
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
The Medicines and Healthcare products Regulatory Agency published a recall notice for Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21 on 23 Apr 2026. It is one of 17 notices of this kind from MHRA since 26 Mar 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Medicines and Healthcare products Regulatory Agency
- Issued
- 11:01, 23 Apr 2026
- Alert class
- Class 3 Recall
- Official source
- Medicines and Healthcare products Regulatory Agency: the notice at its source
The latest from the MHRAEvery warning and recall in the United Kingdom
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains public sector information licensed under the Open Government Licence v3.0.
The notice as issued
Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of Napralief 250mg…
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. The text is the agency's, unedited. Contains public sector information licensed under the Open Government Licence v3.0.